Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • secrtztn secrtztn Aug 17, 2010 7:51 AM Flag

    IPXL - Long Term Prospects

    You need to give the company a little time. There is a lot on the horizon, and the Company has demonstrated competency.

    1. Considerable cash balance.
    2. W/o Cash, trades at 8X earnings
    3. Management looking at an accretive acquisition. I'd expect $100M to $150M of EBITDA.
    4. Expect Adderall XR Sales increases
    5. Company is the first to file on Concerta. JNJ's patent was invalidated.
    6. Detrol LA - settlement is likely.
    7. IPX066 - considerable earnings potential down the road.
    8. Manufacturing in Taiwan - costs driven down/tax savings.
    8. Pipeline - Doryx 150 mg, Renvela, Effexor XR, Solodyn, Renagel, Amrix, Trilipix, Welchol, Fenoglide, Oracea, Tricor, Cymbalta

    Stayed tuned throughout 2011. A LOT on the Horizon.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
46.23-0.15(-0.32%)May 4 4:00 PMEDT